Catherine Atkinson, MP for Derby North, visited leading electronics manufacturer Tioga Limited on Thursday 24th July to learn more about the company’s advanced manufacturing capabilities, commitment to skilled local employment, and transition to employee ownership. Tioga Limited, based in Derby, provides contract electronics manufacturing services to customers in the medical,...
Blüm Technologies Group Ltd Acquires Triscribe Ltd, it’s third NHS Cost Improvement Solution
Blüm Technologies Group is pleased to announce the acquisition of Triscribe, an innovative provider of medicines optimisation and ePMA analytics solutions for the NHS. This acquisition marks a significant step in Blüm’s commitment to helping healthcare organisations reduce unnecessary spending, improve patient safety, and accelerate digital transformation across the health...
V Formation expands digital team
Nottingham-based marketing and communications agency V Formation has welcomed Bella Quach to the team as Paid Media Specialist in response to increasing demand for its digital marketing services. With more than ten years’ experience in digital marketing, Bella brings specialist expertise in paid search campaigns across google and social media,...
Leading lights of UK research spearhead search for world’s best talent
Congratulations to our Patron Member, the University of Warwick, on being named one of just 12 UK institutions selected to deliver the government’s new £54 million Global Talent Fund. This prestigious initiative will see each institution receive an equal share to attract the world’s brightest researchers in critical growth areas,...
Cytecom accelerates diagnostic innovation with WMHTIA support
Cytecom, a University of Warwick spin-out, is taking the lead against antimicrobial resistance (AMR) with its breakthrough diagnostic technology, CyteCount. The company, supported by Medilink Midlands through the West Midlands Health Tech Innovation Accelerator (WMHTIA), is developing a rapid diagnostic platform that identifies the most effective antibiotics for bloodstream infections...
The impact of local cancer research
Hope Against Cancer, a local charity who focus on funding world-class cancer research, treatment and care right here in the East Midlands, have released their latest Impact Report covering the years 2018 – 2024. The report highlights the incredible achievements in local cancer research which is mainly funded by local...
2025’s Medilink UK National Awards Winners
On Thursday 10th July 2025, the winners of the 2025 Medilink UK National Awards attended this year’s awards ceremony. We would like to thank The London Institute for Healthcare Engineering (LIHE) for supporting the event and providing stunning event photography opportunities overlooking the UK Houses of Parliament. We would also like to thank our...
What the NHS 10-Year Plan means for innovation – and your business
The government’s new 10-Year Health Plan shows a bold shift in NHS priorities – towards community-based care, digital innovation, and prevention. For the life sciences and medtech sector, this opens the door to new collaborations, technologies, and patient-centred solutions. Medilink Midlands welcomes the recognition that industry, academia, and third-sector partners...
Strengthening Transatlantic Ties: Medilink Midlands Trade Mission to Mentor, Ohio
Medilink Midlands is inviting expressions of interest from life science and medtech companies across the region to join a strategic trade mission to Mentor, Ohio, from 26–29 October 2025 - deepening a long-standing and productive collaboration between the two regions. This visit marks the next chapter in a well-established partnership...
‘Rebel’ spirit needed to drive healthtech sector growth in the East Midlands, experts say
A recent roundtable hosted by The Boda Group and Shakespeare Martineau echoed what we at Medilink Midlands have long recognised: the East Midlands' healthtech and life sciences sector has no shortage of ambition, but to unlock its full potential, we need to invest in people, not just products. A ‘rebel’...









